Biogena Group Invest AG (WBO:BIO) Cost of Goods Sold : €0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Cost of Goods Sold?

Biogena Group Invest AG's cost of goods sold for the six months ended in Jan. 2024 was €0.00 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Jan. 2024 was €0.00 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biogena Group Invest AG's Gross Margin % for the six months ended in Jan. 2024 was 99.4%.

Cost of Goods Sold is also directly linked to Inventory Turnover.

Biogena Group Invest AG Cost of Goods Sold Historical Data

The historical data trend for Biogena Group Invest AG's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Cost of Goods Sold Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Cost of Goods Sold

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
Cost of Goods Sold	-	-	-	-

Biogena Group Invest AG Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cost of Goods Sold for the trailing twelve months (TTM) ended in Jan. 2024 was €0.00 Mil.

Biogena Group Invest AG (WBO:BIO) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biogena Group Invest AG's Gross Margin % for the six months ended in Jan. 2024 is calculated as:

Gross Margin %	=	(Revenue	-	Cost of Goods Sold)	/	Revenue
	=	(0.166	-	0.001)	/	0.166
	=	99.4 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Biogena Group Invest AG's Inventory Turnover for the six months ended in Jan. 2024 is calculated as:

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.001	/	0
	=	N/A

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.

Biogena Group Invest AG Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Cost of Goods Sold

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.